Spissinger Allan Horst 4
4 · Lexaria Bioscience Corp. · Filed Mar 24, 2020
Insider Transaction Report
Form 4
Transactions
- Other
stock options
2020-03-23−200,000→ 300,000 totalExercise: $0.83From: 2017-12-01Exp: 2022-12-01→ common shares (200,000 underlying) - Other
stock options
2020-03-23−150,000→ 500,000 totalExercise: $0.37From: 2017-06-01Exp: 2022-06-01→ common shares (150,000 underlying) - Other
stock options
2020-03-23−300,000→ 0 totalExercise: $1.53From: 2018-05-31Exp: 2023-05-31→ common shares (300,000 underlying)
Holdings
- 350,000
stock options
Exercise: $0.83From: 2017-12-01Exp: 2022-12-01→ common shares (200,000 underlying) - 150,000
stock options
Exercise: $0.37From: 2017-06-01Exp: 2022-06-01→ common shares (150,000 underlying) - 119,116
common shares
- 650,000
stock options
Exercise: $1.53From: 2018-05-31Exp: 2023-05-31→ common shares (300,000 underlying)
Footnotes (1)
- [F1]Cancellation of Options